Delivery Order V797P7162A-N6890815F0015
Award Date 9/29/15
Potential Completion Date 9/30/16
Potential Value $82K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Quantico, VA 22134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, identified as SPE2DE21D0007|SPE2D625F1R4B, was issued by the Medical Supply Chain, a component of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,832.54 fixed-price contract with economic price adjustment is for the delivery of "ANTI-A BIOCLONE 15X10ML" medical supplies. This appears to be a delivery order under a larger contract vehicle, as the award notice references Ortho-Clinical...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-B Bioclone 15x10ML on August 11, 2025, with completion targeted for August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, headquartered in Raritan, New Jersey, is a for-profit medical equipment manufacturer specializing...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of anti-A bioclone 15x10ml. The contract was awarded by the Medical Supply Chain, a component of the Defense agency, and has a ceiling value of $1,832.54. The contract is a Delivery Order with a fixed price and economic price adjustment pricing type, and has an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating...
- This federal contract award is for the provision of REAGENTS CPRR by Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer, to the Department of the Army Medical Command. The $379,016.47 firm fixed price contract does not have a set-aside designation and was awarded on April 1, 2017 with a completion date of September 30, 2018. Ortho-Clinical Diagnostics Inc. is the prime contractor and has not identified any major subcontractors. The company provides a wide range of...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10ML on August 1, 2025, with an ultimate completion date of August 6, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Performance will occur at the contractor's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc., a for-profit...
- This federal contract award is for LAB REAGENTS AND SUPPLIES to be provided by the prime contractor, Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract has a ceiling value of $115,592.56 and was awarded on December 7, 2016 by the Bureau of Medicine and Surgery, a Defense agency, under a Delivery Order contract type with a Firm Fixed Price pricing structure. The contract is associated with the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule master...
- This federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturing company, was issued by the Defense Logistics Agency Troop Support Medical, part of the Department of Defense. The $2,748.81 firm fixed-price delivery order is for 4,564,275,330 units of an anti-A blood grouping reagent used in clinical laboratory applications. The award has no set-aside designation and an ultimate completion date of April 18, 2024. Ortho-Clinical Diagnostics has provided...
- This federal contract award is for the procurement of BLOOD BANK REAGENTS by the Bureau of Medicine and Surgery, a defense agency. The contract was awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, on a firm fixed price basis for $59,560.57. The contract does not have a set-aside designation. Ortho-Clinical Diagnostics is a vendor that has provided a range of medical equipment, reagents, and services to various federal agencies, including the Department of...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract is for the delivery of REAGENT ANTI-A B BIOCLONE 10ML BOTTLE OR, a medical diagnostic product. The contract is a Delivery Order with a Firm Fixed Price of $1,963.68 and an ultimate completion date of April 21, 2025. There is no set-aside designation for this contract. Ortho-Clinical Diagnostics, Inc. is a...
- This is a $1,832.54 delivery order awarded by the Medical Supply Chain, a division of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of "ANTI-A BIOCLONE 15X10ML", a medical diagnostic product, with a period of performance through May 2025. The contract has a fixed price with economic price adjustment pricing type and does not utilize any set-aside designations. Ortho-Clinical Diagnostics, Inc. is a...